GMPharma Consult ApS Financials, key figures and credit report
Gross profit -11.1 kDKK FY 2025 +68% vs 2024
EBIT -11.1 kDKK FY 2025 +68% vs 2024
Net debt -24.4 kDKK FY 2025 +68.3% vs 2024
Quick ratio 5.3 FY 2025 +1.5 vs 2024
Income statement (kDKK)
2022 | 2023 | 2024 | 2025 | |
|---|---|---|---|---|
| Fiscal period length | 12 | 12 | 12 | 12 |
| Net sales | 806.88 | |||
| External services | -6.30 | |||
| Gross profit | 720.33 | -14.20 | -34.52 | -11.06 |
| Costs of management | -79.95 | |||
| Employee benefit expenses | -0.31 | |||
| EBIT | 131.94 | -14.51 | -34.52 | -11.06 |
| Other financial income | 0.23 | |||
| Other financial expenses | -2.57 | -1.52 | -1.96 | -18.12 |
| Pre-tax profit | 129.38 | -16.03 | -36.24 | -29.18 |
| Income taxes | -28.87 | 3.18 | -3.18 | |
| Net earnings | 100.51 | -12.84 | -39.43 | -29.18 |
Assets (kDKK)
2022 | 2023 | 2024 | 2025 | |
|---|---|---|---|---|
| Intangible assets total | ||||
| Tangible assets total | ||||
| Investments total | ||||
| Long term receivables total | ||||
| Inventories total | ||||
| Current amounts owed by group member comp. | 3.30 | |||
| Current other receivables | 0.14 | 34.75 | 34.21 | |
| Current deferred tax assets | 3.18 | 7.00 | 14.00 | |
| Short term receivables total | 0.14 | 6.48 | 41.75 | 48.21 |
| Cash and bank deposits | 173.47 | 159.97 | 77.23 | 24.45 |
| Cash and cash equivalents | 173.47 | 159.97 | 77.23 | 24.45 |
| Balance sheet total (assets) | 173.61 | 166.46 | 118.98 | 72.66 |
Equity and liabilities (kDKK)
2022 | 2023 | 2024 | 2025 | |
|---|---|---|---|---|
| Share capital | 40.00 | 40.00 | 40.00 | 40.00 |
| Retained earnings | 100.51 | 87.66 | 48.23 | |
| Profit of the financial year | 100.51 | -12.84 | -39.43 | -29.18 |
| Shareholders equity total | 140.51 | 127.66 | 88.23 | 59.06 |
| Provisions | -28.87 | |||
| Non-current deferred tax liabilities | 28.87 | |||
| Non-current liabilities total | 28.87 | |||
| Current trade creditors | 4.23 | 8.63 | 30.75 | 7.00 |
| Short-term deferred tax liabilities | 28.87 | 0.00 | ||
| Other non-interest bearing current liabilities | 30.16 | 6.60 | ||
| Current liabilities total | 33.10 | 38.79 | 30.75 | 13.60 |
| Balance sheet total (liabilities) | 173.61 | 166.46 | 118.98 | 72.66 |
Secure checkout
Buy AI Credit Risk Report
Pay by card and the report is generated automatically and sent to your email. One-time payment – no subscription.
How it works
- 01 You pay €3 (incl. VAT) securely by card via Stripe.
- 02 You enter your email address in Stripe's payment window – the report is sent there.
- 03 The report is generated automatically and sent as a PDF within 30 minutes.
- 04 If generation should fail, you are not charged.
- 05 You receive the receipt by email once the report has been generated and completed.
Do you want to buy the AI Credit Risk Report (3 EUR / report)?
The report is sent to the email address you enter in Stripe's payment window. Please also check your spam folder. Questions? Write to info@creditreports.dk.
Page generated